Biocryst Pharmaceuticals (BCRX) Debt Ratio (2011 - 2026)
Biocryst Pharmaceuticals' Debt Ratio came in at 0.79 for Q2 2026, up 29.2% from 0.61 a year earlier but down 15.9% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Debt Ratio (2011 - 2026) Analysis & Trends
For FY2025, Biocryst Pharmaceuticals' Debt Ratio was 0.07, down 89.4% from FY2024.
- Going back by year, Debt Ratio was 0.71 in FY2024 (+12.1%), 0.63 in FY2023 (+50.1%), 0.42 in FY2022 (+82.0%) and 0.23 in FY2021 (-48.3%).
- The five-year range for quarterly Debt Ratio is 0.07 (Q4 2025) to 0.94 (Q1 2026).
- Year-over-year, Debt Ratio increased in five of the last eight quarters, with an average decline of 4.5%.
- The fastest year-over-year change in Debt Ratio over five years came in Q2 2023 (growth of 95.5%), and the weakest in Q4 2025 (a decline of 89.4%).
- Business Quant data shows BCRX's Debt Ratio at 0.94 (Q1 2026), 0.07 (Q4 2025) and 0.52 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 0.39 |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 0.24 |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 0.52 |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 0.42 |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 0.60 |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 0.53 |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 0.31 |
| 10 | Biocryst Pharmaceuticals | 2.00 Bn | 922.90 Mn | 214.41 Mn | 0.79 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.79 |
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.52 |
| Jun 30, 2025 | 0.61 |
| Mar 31, 2025 | 0.73 |
| Dec 31, 2024 | 0.71 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.71 |
| Dec 31, 2023 | 0.63 |
| Sep 30, 2023 | 0.57 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 0.42 |
| Sep 30, 2022 | 0.40 |
| Jun 30, 2022 | 0.28 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | 0.23 |
| Sep 30, 2021 | 0.61 |
API Access
Biocryst Pharmaceuticals Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();